Effective January 25, 2014, the Bioanalytical Systems Inc.'s Board of Directors elected Merrill R. Osheroff, Ph.D., as a Class II director of the company, replacing David W. Crabb, M.D., who resigned on January 6, 2014. Dr. Osheroff was also appointed to the Compensation Committee of the Board of Directors. Dr. Osheroff's term will expire with the other Class II directors at the 2014 annual meeting of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 USD | -3.10% | +25.14% | -40.33% |
06-04 | Inotiv, Inc. Enters into A Fifth Amendment to the Credit Agreement | CI |
06-03 | Inotiv to Pay $35 Million for Canine-Breeding Facility Violations | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.33% | 56.88M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+46.17% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- NOTV Stock
- News Inotiv, Inc.
- Bioanalytical Systems Inc. Appoints Merrill R. Osheroff as Class II Director and to the Compensation Committee of the Board of Directors Effective January 25, 2014